Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience.
Iastrebner M, Jang JH, Nucifora E, Kim K, Sackmann F, Kim DH, Orlando S, Jung CW, Basquiera A, Klein G, Santini F, Bernard HI, Korin J, Taborda G. Iastrebner M, et al. Among authors: klein g. Leuk Lymphoma. 2010 Dec;51(12):2250-7. doi: 10.3109/10428194.2010.524324. Epub 2010 Oct 7. Leuk Lymphoma. 2010. PMID: 20929328 Clinical Trial.
Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO).
Basquiera AL, Rivas MM, Remaggi G, Klein G, Milovic V, Foncuberta MC, Saba S, Milone JH, Arbelbide J, Jaimovich G, Rolón JM, Kusminsky G, García JJ, Prates MV. Basquiera AL, et al. Among authors: klein g. Hematology. 2016 Apr;21(3):162-9. doi: 10.1179/1607845415Y.0000000028. Epub 2015 Jul 6. Hematology. 2016. PMID: 26147089 Clinical Trial.
Induction of anti-tumor activity following autologous stem cell transplantation: immunotherapeutic implications.
Marin GH, Menna ME, Bergna MI, Malacalza J, Martin C, Mendez MC, Klein G, Montero-Labat L, Gil MA, Saba S, Gardenal L, Mansilla E, Orlando S, Canepa C, Piccinelli G. Marin GH, et al. Among authors: klein g. Transplant Proc. 2001 Feb-Mar;33(1-2):2004-7. doi: 10.1016/s0041-1345(00)02769-x. Transplant Proc. 2001. PMID: 11267604 Clinical Trial. No abstract available.
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Marin GH, Mendez MC, Menna ME, Malacalza J, Bergna MI, Klein G, Italiano C, Perez M, Gil MA, Gardenal L, Mansilla E, Orlando S, Saba S, Cánepa C, Piccinelli G. Marin GH, et al. Among authors: klein g. Transplant Proc. 1999 Sep;31(6):2582-4. doi: 10.1016/s0041-1345(99)00511-4. Transplant Proc. 1999. PMID: 10500728 No abstract available.
Flow cytometric analysis of lymphocyte subsets as a predictive factor for GVHD in allogeneic bone marrow transplantation.
Marin GH, Menna ME, Saba S, Klein G, Mendez MC, Bergna MI, Italiano C, Malacalza J, Perez M, Gil MA, Gardenal L, Orlando S, Mansilla E, Cánepa C, Piccinelli G. Marin GH, et al. Among authors: klein g. Transplant Proc. 1999 Nov;31(7):2973-5. doi: 10.1016/s0041-1345(99)00631-4. Transplant Proc. 1999. PMID: 10578354 No abstract available.
Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience.
Koziner B, Dengra C, Lucero G, Klein G, Cánepa C, Milovic V, Milone G, Robinson A, Cerutti I, Saporito G, Kusminsky G, Milone J, Bordone J, Lastiri F; Argentine Group of Bone Marrow Transplantation. Koziner B, et al. Among authors: klein g. Cancer. 2002 Dec 1;95(11):2339-45. doi: 10.1002/cncr.10931. Cancer. 2002. PMID: 12436440 Free article.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact.
Boess FG, Scelsi MA, Grimmer T, Perry RJ, Tonietto M, Klein G, Hofmann C, Salami M, Wojtowicz J, Lansdall CJ, Lane C, Kerchner GA, Smith J, Doody RS. Boess FG, et al. Among authors: klein g. J Prev Alzheimers Dis. 2024;11(3):537-548. doi: 10.14283/jpad.2024.60. J Prev Alzheimers Dis. 2024. PMID: 38706270 Clinical Trial.
3,465 results